Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Globus Medical, Inc. Class A Common Stock (NY:GMED)

59.92 +0.37 (+0.62%)
Official Closing Price Updated: 7:00 PM EDT, Jun 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Globus Medical Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
7 Analysts Have This to Say About Globus Medical
Via Benzinga
What 5 Analyst Ratings Have To Say About Globus Medical
Via Benzinga
Wells Fargo Maintains Overweight Rating for Globus Medical: Here's What You Need To Know
Via Benzinga
2 Bear Market Stocks That Can Make You Richer in 2022 and Beyond
A bear market can present fresh opportunities for long-term investors. 
Via The Motley Fool
Globus Medical (GMED) Q3 2022 Earnings Call Transcript
GMED earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Analyst Ratings for Globus Medical
Within the last quarter, Globus Medical (NYSE:GMED) has observed the following analyst ratings: 
Via Benzinga
Expert Ratings for Globus Medical
Analysts have provided the following ratings for Globus Medical (NYSE:GMED) within the last quarter: 
Via Benzinga
Short Volatility Alert: Globus Medical, Inc.
On Thursday, shares of Globus Medical, Inc. (NYSE: GMED) experienced volatile short activity. After the activity, the stock price went up +1.83% to $62.78. The overall sentiment for GMED has been... 
Via Benzinga
Globus Medical Reports Third Quarter 2022 Results
From Globus Medical
Via GlobeNewswire
Globus Medical's Earnings Outlook
Globus Medical (NYSE:GMED) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Globus Medical... 
Via Benzinga
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
Globus Medical's Return On Invested Capital Insights
Pulled from Benzinga Pro data, Globus Medical (NYSE:GMED) posted Q1 earnings of $38.08 million, an increase from Q4 of 152.11%. Sales dropped to $230.55 million, a 7.79% decrease between quarters. 
Via Benzinga
What 6 Analyst Ratings Have To Say About Globus Medical
Analysts have provided the following ratings for Globus Medical (NYSE:GMED) within the last quarter: 
Via Benzinga
Globus Medical Issues Softer Outlook For Q1, CEO Resigns
Via Benzinga
Where Globus Medical Stands With Analysts
Analysts have provided the following ratings for Globus Medical (NYSE:GMED) within the last quarter: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
Upgrades 
Via Benzinga
Globus Medical: Q1 Earnings Insights
Globus Medical (NYSE:GMED) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:15 PM. Here's what investors need to know about the announcement. Earnings Globus Medical missed estimated... 
Via Benzinga
Globus Medical's Q4 Earnings Beat Estimates, But FY22 Outlook Lags
Globus Medical Inc's (NYSE: GMED) Q4 sales rea 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Upgrades 
Via Benzinga
Globus Medical Earnings Perspective: Return On Invested Capital
  
Via Benzinga
Analyst Ratings for Globus Medical
Globus Medical (NYSE:GMED) has observed the following analyst ratings within the last quarter: 
Via Benzinga
What 5 Analyst Ratings Have To Say About Globus Medical
Globus Medical (NYSE:GMED) has observed the following analyst ratings within the last quarter: 
Via Benzinga
55 Biggest Movers From Friday
Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 100.9% to close at $2.27 on Friday. Vallon Pharmaceuticals engaged Ladenburg Thalmann & Co Inc to evaluate... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 28, 2022
Upgrades 
Via Benzinga
Health Care Stocks Could Use A Surgical Boom — Will It Happen For Stryker, Boston Scientific, Others?
Elective procedures are recovering slowly as Covid cases decline. Will they ever boom? 
Via Investor's Business Daily
Globus Medical's Return on Invested Capital Insights
Pulled from Benzinga Pro data, Globus Medical (NYSE:GMED) showed a loss in earnings since Q3, totaling $15.11 million. Sales, on the other hand, increased by 8.84% to $250.02... 
Via Benzinga
Expert Ratings For Globus Medical
Within the last quarter, Globus Medical (NYSE:GMED) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total... 
Via Benzinga
The Daily Biotech Pulse: Regeneron-Sanofi Halt Late-Stage Dupixent Study, Agios Gets FDA Nod, Safety Scare For GSK's RSV Vaccine, Shockwave Jumps On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Agios's Metabolic Disorder Treatment Receives FDA Approval (NASDAQ: AGIO... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.